A Look At Howard Hughes Holdings (HHH) Valuation After Recent Share Price Weakness

Howard Hughes Holdings Inc.

Howard Hughes Holdings Inc.

HHH

0.00

What recent performance says about Howard Hughes Holdings

With no single headline event in focus, Howard Hughes Holdings (HHH) has drawn attention after a mixed stretch, including a roughly 22% decline over the past 3 months alongside modest revenue and net income growth.

That recent 22.6% 90 day share price decline, alongside a 19.4% year to date share price return decline and a 9.2% 1 year total shareholder return decline, signals fading momentum despite annual revenue and net income growth on the latest figures.

If this kind of mixed setup has you comparing other opportunities, it could be a good time to broaden your watchlist with 18 top founder-led companies

With revenue and net income both growing while the stock sits well below analyst targets and intrinsic estimates, the key question is whether Howard Hughes Holdings is genuinely undervalued or whether the market is already pricing in future growth.

Most Popular Narrative: 32.9% Undervalued

With Howard Hughes Holdings last closing at $63.52 against a narrative fair value of $94.67, the current setup centers on whether long term transformation can justify that gap.

The pending acquisition and integration of a cash-generative insurance operation will diversify the earnings base, deploy excess capital into higher-yielding investments, and leverage Pershing Square's proven investment management expertise, which together are likely to significantly enhance long-term earnings power, return on equity, and share value compounding.

Analysts are incorporating a scenario with a step up in profitability, a richer mix of recurring income, and a very specific future earnings multiple to land on that valuation. The full narrative spells out how steady top line assumptions, widening margins and share count changes all feed into that price target. If you want to see exactly which expectations have to line up for $94.67 to be supported, the detailed model is worth a read.

Result: Fair Value of $94.67 (UNDERVALUED)

However, this hinges on a smooth pivot into insurance and the management of US$5.2b of debt, where integration issues or refinancing pressure could quickly challenge that thesis.

Another way to look at valuation

That $94.67 fair value from the narrative sits beside a very different signal from simple earnings multiples. At a P/E of 30.3x, Howard Hughes Holdings trades above the US Real Estate industry at 29.1x and roughly double the 15x peer average, even though the fair ratio sits higher at 32.5x.

In plain terms, the stock already assumes richer earnings than many peers, while still sitting below where the fair ratio suggests the P/E could move. For you, that mix can mean more room for sentiment to swing the share price in both directions. Consider which side of that trade off feels more realistic for your own expectations.

NYSE:HHH P/E Ratio as at May 2026
NYSE:HHH P/E Ratio as at May 2026

Next Steps

This mix of pressure and potential does not have to feel confusing. You can move quickly, review the underlying data, and decide where you stand using our breakdown of 3 key rewards and 2 important warning signs

Looking for more investment ideas?

If you stop with just one stock, you risk missing out on other clear opportunities, so use the screener to widen your field of serious contenders.

  • Target potential mispricings by hunting for companies that combine quality with room for a re rating using 51 high quality undervalued stocks.
  • Prioritize resilience by focusing on companies that pair healthy finances with staying power through the solid balance sheet and fundamentals stocks screener (44 results).
  • Get ahead of the crowd by spotting lesser known opportunities with strong fundamentals via the screener containing 23 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.